EcoDrugPlus

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSSARG00000008798
Gene Symbol: IKBKB
1 External references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSSARG00000013479
Gene Symbol: IMPDH1
1 External references
330 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSSARG00000000060
Gene Symbol: IMPDH2
3 External references
200 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSSARG00000004582
Gene Symbol: ITGA4
3 External references
236 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSSARG00000002874
Gene Symbol: ITGB1
1 External references
298 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSSARG00000014093
Gene Symbol: ITGB5
1 External references
210 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSSARG00000005826
Gene Symbol: ITGB8
1 External references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSSARG00000009003
Gene Symbol: IRAK4
3 External references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSSARG00000011779
Gene Symbol: IL5
3 External references
91 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSSARG00000012781
Gene Symbol: IL6
3 External references
162 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSSARG00000011164
Gene Symbol: IDH1
1 External references
234 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSSARG00000010245
Gene Symbol: KLKB1
1 External references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).